Anemia with intrinsic hemolysis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Differentiating Anemia with intrinsic hemolysis from Other Diseases
Differentiating Anemia with intrinsic hemolysis from Other Diseases
To review the differential diagnosis of anemia, click here.
| Disease | Genetics | Clinical manifestation | Lab findings | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| History | Symptoms | Signs | Hemolysis | Intrinsic/Extrinsic | Hb concentration | MCV | RDW | Reticulocytosis | Haptoglobin levels | Hepcidin | Iron studies | Specific finding on blood smear | ||||||
| Serum iron | Serum Tfr level | Transferrin or TIBC | Ferritin | Transferrin saturation | ||||||||||||||
| G6pd deficiency[1] |
|
+ | Intrinsic | Normochromic | Normocytic | β | β but usually causes resolution within 4-7 days | β | β | Nl to β | Nl | β | β | β |
| |||
| Pyruvate kinase deficiency[2] |
|
|
|
+ | Intrinsic | Normochromic | Normocytic | β | β | β | Nl | β | Nl | Nl | β | β |
| |
| Sickle cell anemia[3] |
|
|
+ | Intrinsic | Normochromic | Normocytic | β | β | β | Nl or moderately β | Nl | Nl | Nl or moderately β | β | Nl |
| ||
| Disease | Genetics | History | Symptoms | Signs | Hemolysis | Intrinsic/Extrinsic | Hb concentration | MCV | RDW | Reticulocytosis | Haptoglobin levels | Hepcidin | Serum iron | Serum Tfr level | IBC | Ferritin | Transferrin saturation | Specific finding on blood smear |
| HbC disease[4] |
|
|
+ | Intrinsic | Normochromic | Normocytic | β | β | β | Nl | Nl | Nl | Nl | β | β |
| ||
| Paroxysmal nocturnal hemoglobinuria[5][6] |
|
|
|
|
+ | Intrinsic | Normochromic | Normocytic | β | β | β | Nl | β | Nl | β | β | β | NA |
| Hereditary spherocytosis[7] |
|
|
+ | Intrinsic | Normochromic | Normocytic | β | β | β | Nl | β | Nl | β | Nl | β |
| ||
References
References
- β Luzzatto L, Seneca E (February 2014). “G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications”. Br. J. Haematol. 164 (4): 469β80. doi:10.1111/bjh.12665. PMCΒ 4153881. PMIDΒ 24372186.
- β Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B (September 2015). “Erythrocyte pyruvate kinase deficiency: 2015 status report”. Am. J. Hematol. 90 (9): 825β30. doi:10.1002/ajh.24088. PMCΒ 5053227. PMIDΒ 26087744.
- β Singh PC, Ballas SK (March 2015). “Emerging drugs for sickle cell anemia”. Expert Opin Emerg Drugs. 20 (1): 47β61. doi:10.1517/14728214.2015.985587. PMIDΒ 25431087.
- β Lemonne N, Billaud M, Waltz X, Romana M, Hierso R, Etienne-Julan M, Connes P (2016). “Rheology of red blood cells in patients with HbC disease”. Clin. Hemorheol. Microcirc. 61 (4): 571β7. doi:10.3233/CH-141906. PMIDΒ 25335812.
- β Bunyaratvej A, Butthep P (January 1992). “Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes”. J Med Assoc Thai. 75 Suppl 1: 237β42. PMIDΒ 1402472.
- β Kahng J, Kim Y, Kim JO, Koh K, Lee JW, Han K (January 2015). “A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data”. Ann Lab Med. 35 (1): 35β40. doi:10.3343/alm.2015.35.1.35. PMCΒ 4272963. PMIDΒ 25553278.
- β Da Costa L, Galimand J, Fenneteau O, Mohandas N (July 2013). “Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders”. Blood Rev. 27 (4): 167β78. doi:10.1016/j.blre.2013.04.003. PMIDΒ 23664421.
Looking for the patient version?
Β© 2026 MyEClinic β IFTM Institut fΓΌr Telematik in der Medizin GmbH
